Medication info
Biswon Tablet

Biswon Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
Green round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201600976 · Approved 2016.02.22

This product's status changed to Expired on 2026.02.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant treatment to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose if needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcers
  • gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drugs
View approved original text

This medication is used for conditions related to the stomach and duodenum, including ulcers, gastritis, and gastroesophageal reflux disease. It is also helpful in treating disorders associated with excessive gastric acid secretion, such as Zollinger-Ellison syndrome. It is utilized for the prevention of Mendelson's syndrome prior to anesthesia and is effective for treating ulcers that may occur post-surgery. It is used for gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). It is applied in the treatment of various gastrointestinal diseases to alleviate symptoms.

How to take

Adult dose

Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant treatment to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose if needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or those who have had allergic reactions to it. It is also unsafe for patients with a history of acute porphyria, those with impaired kidney function, patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants and newborns, and patients with potassium intake restrictions. Patients with compromised liver function or previous experiences of drug allergies, elderly patients, and patients with a history of kidney disease should use this medication with caution. Patients with gastric ulcers or recently developed dyspeptic symptoms should be checked for malignancy before use, as this medication may mask the symptoms of gastric cancer. Patients with Helicobacter pylori infection along with gastric and duodenal ulcers should undergo eradication therapy; other patients, especially those who are critically ill or have hypophosphatemia, may also require caution. While using this medication, various side effects such as shock, severe allergic reactions, skin rashes, blood abnormalities, liver dysfunction, arrhythmias, digestive symptoms, neurological disturbances, muscle pain may occur, so if any abnormal symptoms are observed, discontinue use immediately and consult a doctor. Avoid long-term use, and if there is no therapeutic effect, consider switching to a different medication. Caution is necessary as there may be an increased risk of pneumonia in elderly patients or those with chronic lung disease, diabetes, and impaired immunity. Patients should avoid driving or operating dangerous machinery if dizziness or drowsiness occurs. This medication may interact with other drugs, so consult with a doctor or pharmacist if taking other medications, especially antacids should be taken with an interval. It is safest for pregnant or nursing women not to use this medication, and it is preferable not to administer it to children. Furthermore, this medication may cause false-positive results in urine protein tests, so caution is necessary during testing. In cases of overdose, emergency treatment such as vomiting or gastric lavage may be needed, and blood dialysis may also be considered. Lastly, this medication may reduce gastric acid secretion, leading to an increase in bacterial growth in the gastrointestinal tract, and long-term use may require ocular examinations.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 59 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelodysplasia
  • bone marrow aplasia
  • aplastic anemia
  • secondary autoimmune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • illness sensation
  • anxiety
  • mental confusion
  • depression
  • hallucination
  • blurred vision
  • involuntary movement disorder
  • altered consciousness
  • myotonic cramps
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air from entering, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage helps to maintain the drug’s effectiveness for a longer period.

Appearance and packaging

Appearance

Green round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.